Calgary, Canada
LyfeMD is a digital health technology company headquartered in Canada, founded in 2020, and specializing in addressing gastrointestinal and inflammatory conditions. The company's slogan "A digital health technology company with a solution to improve digestive symptoms, hospitalizations and surgeries" reflects their focus on improving patient outcomes in these areas.
Their platform caters to patients with IBD, NAFLD, IBS, and Inflammatory Arthritis, offering personalized wellness programs grounded in over a decade of scientific research. By leveraging this extensive knowledge base, LyfeMD provides proven, effective strategies for managing these health conditions.
An integral part of the offering is connecting patients with health coaches and registered professionals dedicated to improving health and quality of life. Through these connections, LyfeMD seeks to make every day a healthier day for its users.
The company's most recent investment came in the form of a grant at 22 August 2023, with backing from Startupfest and the Business Development Bank of Canada.
LyfeMD's focused approach to leveraging technology for health improvement, along with its recent investment success, positions it as an intriguing player in the health care industry and a noteworthy prospect for investors seeking opportunities in the digital health sector.
